Survanta Global Market Report 2025

Survanta Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Respiratory Distress Syndrome (RDS), Meconium Aspiration Syndrome (MAS), Bronchopulmonary Dysplasia (BPD), Acute Respiratory Failure, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Public Health Clinics), By End-User (Pediatric)

Name: Survanta Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Survanta Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Survanta Market?

Survanta is a surfactant medication used to treat or prevent respiratory distress syndrome (RDS) in premature infants. It works by replacing the natural surfactant in the lungs, which helps reduce surface tension in the alveoli, improving breathing and oxygen exchange. The medication is administered directly into the lungs to enhance their function and support respiratory stability.

The main indications of survanta are respiratory distress syndrome (RDS), meconium aspiration syndrome (MAS), bronchopulmonary dysplasia (BPD), acute respiratory failure, and other indications. Respiratory Distress Syndrome (RDS) is a condition commonly seen in premature infants where the lungs lack sufficient surfactant, leading to difficulty breathing and inadequate oxygen exchange. It is distributed through various distribution channels, such as hospital pharmacies, retail pharmacies, and public health clinics, and it is used for pediatric patients.

Survanta Market Size and growth rate 2025 to 2029: Graph

What Is The Survanta Market Size 2025 And Growth Rate?

The survanta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the growth of neonatal care, an increase in preterm births, advancements in respiratory care technology, rising awareness about neonatal respiratory diseases, and growing healthcare infrastructure in developing regions.

What Is The Survanta Market Growth Forecast?

The survanta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecasted rising prevalence of respiratory disorders in neonates, advancements in surfactant therapy, increasing government initiatives for neonatal health, growth in neonatal intensive care units (NICUs), and expanding healthcare access in emerging markets. Major trends include advancements in neonatal care, technological innovations, point-of-care diagnostics, telemedicine in neonatal care, and personalized medicine.

Book your 30 minutes free consultation with our research experts

How Is The Survanta Market Segmented?

The survanta market covered in this report is segmented –

1) By Indication: Respiratory Distress Syndrome (RDS); Meconium Aspiration Syndrome (MAS); Bronchopulmonary Dysplasia (BPD); Acute Respiratory Failure; Other Indications

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Public Health Clinics

3) By End-User: Pediatric

What Is Driving The Survanta Market? Impact Of Increasing Prevalence Of Premature Births On The Growth Of The Market

The increasing prevalence of premature births is significantly driving the growth of the survanta market in the future. Premature births occur when a baby is born before 37 weeks of pregnancy, leading to underdeveloped organs and increased health risks. The increasing prevalence of premature births can be attributed to factors such as advanced maternal age, lifestyle choices, increased prevalence of chronic conditions, and advancements in fertility treatments. Survanta is used in premature births to treat respiratory distress syndrome (RDS), a condition common in premature infants due to insufficient surfactant production in their lungs, helping improve lung function and reduce the risk of complications. For instance, in September 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022, the percentage of premature live births in England and Wales increased to 7.9%, up from 7.5% in 2021. Thus, increasing the prevalence of premature births is driving the growth of the survanta market.

What Is Driving The Survanta Market? Impact Of Increasing Investments In Maternal And Child Health On The Growth Of The Market

Increasing investments in maternal and child health are expected to propel the growth of the survanta market going forward. Maternal and child health refers to the well-being of women during pregnancy, childbirth, and the postpartum period, as well as the health and development of children, particularly in the early years of life. Increasing investments in maternal and child health are driven by the need to reduce maternal and infant mortality, improve healthcare access, and promote long-term social and economic development. Investment in maternal and child health ensures access to life-saving treatments such as survanta, reducing neonatal mortality from respiratory distress syndrome. For instance, in September 2024, the American Hospital Association, a US-based professional organization, reported that the Department of Health and Human Services allocated over $558 million (USD 0.558) to maternal health initiatives, including $440 million (USD 0.44) for home visiting services and $118.5 million (USD 0.1185) for CDC programs. Thus, the increasing investments in maternal and child health are driving the growth of the survanta market.

What Is Driving The Survanta Market? Impact Of Rising Infant Hospital Admissions On The Market

The growing number of infant hospital admissions is set to propel the growth of the Survanta market moving forward. The growing number of infants' hospital admissions can be attributed to factors such as increasing rates of premature births, higher incidences of neonatal and respiratory conditions, improved survival rates leading to more complex care needs, and greater access to healthcare facilities. Survanta is utilized during infant hospitalizations to treat respiratory distress syndrome (RDS) in premature newborns, enhancing lung function and minimizing complications. For instance, in May 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, hospital admissions of infants under 14 days increased from 81.6 per 1,000 population in the fiscal year 2022 to 84.8 per 1,000 population in the fiscal year 2023. Therefore, the growing number of infant hospital admissions will drive the growth of the survanta market.

Who Are The Major Players In The Global Survanta Market?

Major companies operating in the survanta market are AbbVie Ltd.

Regional Analysis For The Global Survanta Market

North America was the largest region in the survanta market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the survanta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the survanta market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Survanta Market?

The survanta market consists of sales of surfactant delivery devices, neonatal respiratory care kits, syringes, and injection systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Survanta Industry?

The survanta market research report is one of a series of new reports from The Business Research Company that provides survanta market statistics, including the survanta industry global market size, regional shares, competitors with the survanta market share, detailed survanta market segments, market trends, and opportunities, and any further data you may need to thrive in the survanta industry. This survanta market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Survanta Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The survanta market covered in this report is segmented – 1) By Indication: Respiratory Distress Syndrome (RDS); Meconium Aspiration Syndrome (MAS); Bronchopulmonary Dysplasia (BPD); Acute Respiratory Failure; Other Indications 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Public Health Clinics 3) By End-User: Pediatric
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	AbbVie Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Survanta Market Characteristics

3. Survanta Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Survanta Market Trends And Strategies

5. Survanta Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Survanta Growth Analysis And Strategic Analysis Framework

6.1. Global Survanta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Survanta Market Growth Rate Analysis

6.4. Global Survanta Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Survanta Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Survanta Total Addressable Market (TAM)

7. Global Survanta Pricing Analysis & Forecasts

8. Survanta Market Segmentation

8.1. Global Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Respiratory Distress Syndrome (RDS)

Meconium Aspiration Syndrome (MAS)

Bronchopulmonary Dysplasia (BPD)

Acute Respiratory Failure

Other Indications

8.2. Global Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Retail Pharmacies

Public Health Clinics

8.3. Global Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric

9. Global Survanta Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Survanta Market Regional And Country Analysis

10.1. Global Survanta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Survanta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Survanta Market

11.1. Asia-Pacific Survanta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Survanta Market

12.1. China Survanta Market Overview

12.2. China Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Survanta Market

13.1. India Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Survanta Market

14.1. Japan Survanta Market Overview

14.2. Japan Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Survanta Market

15.1. Australia Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Survanta Market

16.1. South Korea Survanta Market Overview

16.2. South Korea Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Survanta Market

17.1. Western Europe Survanta Market Overview

17.2. Western Europe Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Survanta Market

18.1. UK Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Survanta Market

19.1. Germany Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Survanta Market

20.1. France Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Survanta Market

21.1. Eastern Europe Survanta Market Overview

21.2. Eastern Europe Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Survanta Market

22.1. North America Survanta Market Overview

22.2. North America Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Survanta Market

23.1. USA Survanta Market Overview

23.2. USA Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Survanta Market

24.1. Canada Survanta Market Overview

24.2. Canada Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Survanta Market

25.1. South America Survanta Market Overview

25.2. South America Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Survanta Market

26.1. Middle East Survanta Market Overview

26.2. Middle East Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Survanta Market

27.1. Africa Survanta Market Overview

27.2. Africa Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Survanta Market Competitive Landscape And Company Profiles

28.1. Survanta Market Competitive Landscape

28.2. Survanta Market Company Profiles

28.2.1. AbbVie Ltd. Overview, Products and Services, Strategy and Financial Analysis

29. Global Survanta Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Survanta Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Survanta Market

32. Recent Developments In The Survanta Market

33. Survanta Market High Potential Countries, Segments and Strategies

33.1 Survanta Market In 2029 - Countries Offering Most New Opportunities

33.2 Survanta Market In 2029 - Segments Offering Most New Opportunities

33.3 Survanta Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Survanta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Survanta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: AbbVie Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Survanta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Survanta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Survanta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Survanta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Survanta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: AbbVie Ltd. Financial Performance

ACE Inhibitors Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights

Analyzing the Future of Acute Ischemic Stroke Drugs Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

Unlocking the Future of the Albumin Excipient Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Top Growth Trends in the Angina Pectoris Drugs Market: Key Insights and Opportunities for 2025-2034

Unlocking Opportunities in the Anti-Aging Drugs Market: Key Growth Trends and Forecast Insights

Anticonvulsants Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

Anti-Vascular Endothelial Growth Factor Therapeutics Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead

Future Outlook of the Antivenom Market: Growth, Trends, and Emerging Opportunities Explored

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lung Cancer Diagnostic And Screening Global Market Report 2025 – By Product (Instruments, Consumables And Accessories), By Test (Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests), By Cancer Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer), By End User (Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Small Cell Lung Cancer Therapeutics Global Market Report 2025 – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administrations), By End-Users (Hospitals, Cancer Therapy Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Black Lung Disease Global Market Report 2025 – By Type (Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types), By Treatment (Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment), By Diagnosis (Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis), By End Users (Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interstitial Lung Disease Global Market Report 2025 – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonitis, Hypersensitivity Pneumonitis, Cryptogenic Organizing Pneumonia (COP), Sarcoidosis, Acute Interstitial Pneumonitis), By Application (Adults, Children), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2025 – By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Other Types), By Therapy (Radiotherapy, Laserthearpy, Photodynamic Therapy (PDT), Other Therapies), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Premature Ejaculation Treatment Global Market Report 2025 – By Type (Antidepressants (SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment), By Route of Administration (Oral, Topical), By Distribution Channel (Retail, Direct-To-Consumer), By Application (Hospital, Retail Pharmacy, Online Pharmacy, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Smart Baby Monitor Global Market Report 2025 – By Product (Audio And Video, Tracking Device), By Connectivity (Wired, Wireless), By Distribution Channel (Hypermarket Or Supermarket, Wholesalers Or Distributors, Specialty Stores, Independent Stores, Online Retailers, Other Sales Channel), By Application (Home or Family, Commercial, Daycare, Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Survanta market?

How will the Survanta market drivers and restraints affect the market dynamics? What forces will shape the Survanta industry going forward?

The Survanta market major growth driver - Impact Of Increasing Prevalence Of Premature Births On The Growth Of The Market. For further insights on the Survanta market, request a sample here

What is the forecast market size or the forecast market value of the Survanta market?

The Survanta market size has grown strongly in recent years. The survanta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the growth of neonatal care, an increase in preterm births, advancements in respiratory care technology, rising awareness about neonatal respiratory diseases, and growing healthcare infrastructure in developing regions. The survanta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecasted rising prevalence of respiratory disorders in neonates, advancements in surfactant therapy, increasing government initiatives for neonatal health, growth in neonatal intensive care units (NICUs), and expanding healthcare access in emerging markets. Major trends include advancements in neonatal care, technological innovations, point-of-care diagnostics, telemedicine in neonatal care, and personalized medicine. For further insights on the Survanta market, request a sample here

How is the Survanta market segmented?

The survanta market covered in this report is segmented –
1) By Indication: Respiratory Distress Syndrome (RDS); Meconium Aspiration Syndrome (MAS); Bronchopulmonary Dysplasia (BPD); Acute Respiratory Failure; Other Indications
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Public Health Clinics
3) By End-User: Pediatric For further insights on the Survanta market, request a sample here

Which region has the largest share of the Survanta market? What are the other regions covered in the report?

Who are the major players in the Survanta market?

Major companies operating in the survanta market are AbbVie Ltd. . For further insights on the Survanta market, request a sample here.

What are the key trends in the Survanta market?

Major trends in the Survanta market include . For further insights on the Survanta market, request a sample here.

What are the major opportunities in the Survanta market? What are the strategies for the Survanta market?

For detailed insights on the major opportunities and strategies in the Survanta market, request a sample here.

How does the Survanta market relate to the overall economy and other similar markets?

For detailed insights on Survanta's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Survanta industry?

For detailed insights on the mergers and acquisitions in the Survanta industry, request a sample here.

What are the key dynamics influencing the Survanta market growth? SWOT analysis of the Survanta market.

For detailed insights on the key dynamics influencing the Survanta market growth and SWOT analysis of the Survanta industry, request a sample here.

Survanta Global Market Report 2025

Survanta Global Market Report 2025

What Is Covered Under Survanta Market?

What Is The Survanta Market Size 2025 And Growth Rate?

What Is The Survanta Market Growth Forecast?

How Is The Survanta Market Segmented?

What Is Driving The Survanta Market? Impact Of Increasing Prevalence Of Premature Births On The Growth Of The Market

What Is Driving The Survanta Market? Impact Of Increasing Investments In Maternal And Child Health On The Growth Of The Market

What Is Driving The Survanta Market? Impact Of Rising Infant Hospital Admissions On The Market

Who Are The Major Players In The Global Survanta Market?

Regional Analysis For The Global Survanta Market

What Defines the Survanta Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Survanta Industry?

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions